Universe Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Portfolio Pulse from Benzinga Newsdesk
Universe Pharmaceuticals INC (NASDAQ:UPC) has received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, as its share price has fallen below $1.00 for 30 consecutive business days.
November 01, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Universe Pharmaceuticals has been notified by Nasdaq for not meeting the minimum bid price requirement, as its stock has traded below $1.00 for 30 consecutive days.
The notification from Nasdaq indicates a risk of delisting if Universe Pharmaceuticals does not address the minimum bid price deficiency. This could lead to negative sentiment and pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100